Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 10,000 shares at $14.85 ($149K) on 2026-04-08, disclosed to the SEC on 2026-04-10.
Scheduled sale ($148k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-04 | $392K | — | Filing → |